The Cigna Group
CIThe Cigna Group (CI) is a global health service company that provides insurance plans, related products, and services. It offers health, dental, vision, and pharmacy plans, along with behavioral health services and wellness programs. Founded in 1982 and based in Bloomfield, Connecticut, Cigna focuses on improving health outcomes and enhancing the healthcare experience for individuals and organizations.
Dividend History
Investors can expect a dividend payout of $1.51 per share, scheduled to be distributed in 10 days on December 18, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 18, 2025 | $1.51 | 2025-12-04 | 2025-12-04 |
| September 18, 2025 | $1.51 | 2025-09-04 | 2025-09-04 |
| June 18, 2025 | $1.51 | 2025-06-03 | 2025-06-03 |
| March 20, 2025 | $1.51 | 2025-03-05 | 2025-03-05 |
| December 19, 2024 | $1.40 | 2024-12-04 | 2024-12-04 |
Dividends Summary
- The Cigna Group has issued 49 dividend payments over the past 21 years
- The most recent dividend was paid 81 days ago, on September 18, 2025
- The highest dividend payed out to investors during this period was $1.51 per share
- The average dividend paid during this period was $0.54 per share.
Company News
The White House is preparing to introduce a healthcare framework to extend Affordable Care Act subsidies, proposing a two-year extension with updated eligibility limits and measures to control premium increases affecting approximately 22 million Americans.
Abeona Therapeutics saw a significant stock surge of over 25% after reporting strong Q3 earnings and positive updates on Zevaskyn, its gene therapy treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB), with major insurers now covering the treatment.
Mike Hagan from Smart Medigap Plans provides personalized Medicare insurance consultations, focusing on helping seniors navigate complex insurance options and find affordable healthcare plans.
The executive order aims to lower drug prices in the U.S. by targeting pharmacy benefit managers (PBMs) and their opaque pricing practices. While this could negatively impact PBM companies, pharmaceutical manufacturers may be able to avoid the worst of the price cuts by partnering with PBMs or selling directly to consumers.
Centene Corporation is set to report its second-quarter 2024 results. The company's performance is expected to have benefited from enhanced volumes and contributions from its Commercial business, but declining total memberships and growing cost ratio might affect second-quarter profits.
